Brainstorm Cell Therapeutics (BCLI) Misses Q3 EPS by 19c
Tweet
Share
E-mailGet Alerts BCLI Hot Sheet
Join SI Premium – FREE
Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q3 EPS of ($0.19).
For earnings history and earnings-related data on Brainstorm Cell Therapeutics (BCLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crude Inventory Rose 2.97 Million Barrels Last Week - EIA
- Charter Communications (CHTR) call put ratio 1.6 calls to 1 put as share price near low end of range
- Intuit (INTU) call put ratio 1 call to 1.5 puts as share price down 1.3%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
